138 related articles for article (PubMed ID: 16801018)
1. [Blastic NK-cell lymphoma].
Calvo M; González C; Martín E; Marqués A; Jaén P
Actas Dermosifiliogr; 2006 May; 97(4):253-6. PubMed ID: 16801018
[TBL] [Abstract][Full Text] [Related]
2. [Hematodermic CD4/CD56 neoplasm].
Petrella T; Wechsler J; Courville P; de Muret A; Bosq J; Déchelotte P; Feuillard J; Durlach A; Vergier B
Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
[TBL] [Abstract][Full Text] [Related]
3. Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature.
Argyrakos T; Rontogianni D; Karmiris T; Kapsimali V; Grigoriou E; Tsantekidou M; Naum C; Galani V; Pantelidaki C; Harhalakis N; Nikiforakis E; Kanavaros P
Leuk Lymphoma; 2004 Oct; 45(10):2127-33. PubMed ID: 15370260
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
[TBL] [Abstract][Full Text] [Related]
5. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
7. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
[TBL] [Abstract][Full Text] [Related]
9. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
10. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues].
Zheng YY; Chen G; Zhou XG; Jin Y; Xie JL; Zhang SH; Zhang YN
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587
[TBL] [Abstract][Full Text] [Related]
11. Agranular CD4+/CD56+ hematodermic neoplasm: a distinct entity described in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas.
Niakosari F; Sur M
Arch Pathol Lab Med; 2007 Jan; 131(1):149-51. PubMed ID: 17227117
[TBL] [Abstract][Full Text] [Related]
12. Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma.
Di Mario A; Garzia M; d'Alò F; Rumi C; Massini G; Bellesi S; Zini G
Hematology; 2007 Apr; 12(2):155-7. PubMed ID: 17454197
[No Abstract] [Full Text] [Related]
13. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
[TBL] [Abstract][Full Text] [Related]
14. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
15. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
Shi Y; Wang E
Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
[TBL] [Abstract][Full Text] [Related]
16. [Morphological and immunohistochemical characteristics of blastic NK-cell lymphoma].
Leenman EE; Krivolapov IuA
Arkh Patol; 2005; 67(5):35-7. PubMed ID: 16323479
[TBL] [Abstract][Full Text] [Related]
17. Classification of cytotoxic T-cell and natural killer cell lymphomas.
Jaffe ES; Krenacs L; Raffeld M
Semin Hematol; 2003 Jul; 40(3):175-84. PubMed ID: 12876666
[TBL] [Abstract][Full Text] [Related]
18. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
[TBL] [Abstract][Full Text] [Related]
19. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
[TBL] [Abstract][Full Text] [Related]
20. A case of blastic NK-cell lymphoma.
Akasaka E; Mabuchi T; Umezawa Y; Iwashita K; Ohta Y; Matsuyama T; Ozawa A
Int J Dermatol; 2007 Jul; 46(7):722-6. PubMed ID: 17614802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
